ID
30875
Description
This ODM file contains documentation of concomitant medications. To be checked for (and added if neccessary) at Screening, Sessions 1 and 2 (Day -1), Early Withdrawal and Follow-Up. Study ID: 109710 Clinical Study ID: DAN109710 Study Title: A single-blind, randomized, placebo controlled, two-period crossover fMRI study to investigate the effects of the D3 antagonist GSK598809 on neural and behavioural responses to food reward and reinforcement after a single oral dose of GSK598809 in overweight and obese subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01039454 https://clinicaltrials.gov/ct2/show/NCT01039454 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK598809 Trade Name: Study Indication: Substance Dependence Brief Summary: This novel compound is a new experimental treatment that may help people to stop compulsive overeating. Compulsive overeating or binge eating is one of the main reasons why people are overweight or obese. Recent research has shown that some kinds of overeating may be linked to a brain chemical called dopamine. There is some evidence that blocking the action of this chemical in animals can reduce food intake, particularly of foods that are high in fat and sugar. The purpose of this study is to find out if this compound (which blocks the effects of dopamine) has the same effect in overweight or obese people, as it does in animals.
Link
https://clinicaltrials.gov/ct2/show/NCT01039454
Keywords
Versions (2)
- 6/29/18 6/29/18 - Sarah Riepenhausen
- 6/29/18 6/29/18 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
June 29, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Effects of D3 antagonist GSK598809 on neural and behavioural responses to food reward/reinforcement after a single dose in overweight/obese subjects NCT01039454
Concomitant Medications
- StudyEvent: ODM
Description
Concomitant Medications
Alias
- UMLS CUI-1
- C2347852
Description
If Yes, record each medication in a separate set of the following questions of this itemgroup using Trade Names where possible.
Data type
text
Alias
- UMLS CUI [1]
- C2347852
Description
Trade name preferred, e.g. Aspirin
Data type
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Description
Unit Dose
Data type
float
Alias
- UMLS CUI [1]
- C2826767
Description
Examples: Abbreviation = Label TAB = Tablet MCL = Microlitre ML = Millilitre L = Litre MCG = Microgram MG = Milligram G = Gram
Data type
text
Alias
- UMLS CUI [1]
- C2826646
Description
Examples: Abbreviation = Label OD/QD = 1 x Daily BID = 2 x Daily TID = 3 x Daily QID = 4 x Daily PRN = As required
Data type
text
Alias
- UMLS CUI [1]
- C2826654
Description
Examples: Abbreviation = Label IM = Intramuscular IH = Inhalation IV = Intravenous NS = Nasal TP = Topical PO = Oral VG = Vaginal
Data type
text
Alias
- UMLS CUI [1]
- C2826730
Description
Ensure that the ’Reason for Medication’ is recorded on one of the following pages using the same terms: Current Medical Conditions Non-Serious Adverse Events Serious Adverse Events Form
Data type
text
Alias
- UMLS CUI [1]
- C2826696
Description
Check that either medication start date is completed or ’Taken Prior to Study?’ is ’Yes’. It is acceptable for start date to be missing if ’Taken Prior to Study?’ is ’Yes’. It is acceptable if ’Taken Prior to Study?’ is ’Yes’ and a start date is present, as long as the start date is prior to the date of the subject’s initial visit. Record Unknown months as UNK
Data type
date
Alias
- UMLS CUI [1]
- C2826734
Description
Start Time
Data type
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1301880
Description
Check that either medication start date is completed or ’Taken Prior to Study?’ is ’Yes’. It is acceptable for start date to be missing if ’Taken Prior to Study?’ is ’Yes’. It is acceptable if ’Taken Prior to Study?’ is ’Yes’ and a start date is present, as long as the start date is prior to the date of the subject’s initial visit.
Data type
text
Alias
- UMLS CUI [1]
- C2826667
Description
Check that either medication stop date is completed or ’Ongoing Medication?’ is ’Yes’. It is acceptable for stop date to be missing if ’Ongoing Medication?’ is ’Yes’.
Data type
date
Alias
- UMLS CUI [1]
- C2826744
Description
Stop Time
Data type
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1522314
Description
Ongoing Medication
Data type
text
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant Medications
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
No comments